Epstein Secrets

s about Atlas or openly disputed his views." The Washington Post <https://www.washingtonpost.corn/politics/2020/11/30/scott-atlas-resigns/> (11/30, Dawsey, Abutaleb, 14.2M) reports that while Atlas "fell out of favor with senior White House advisers in recent weeks, he was for several months the only m

BioNTech." In a 2,700-word article, the New York Times <https://www.nytimes.com/2020/11/30/health/coronavirus- vaccines-treatments.html> (11/30, Al, McNeil, 18.61M) says that while "good news about vaccines or antibody treatments surfaces" every week, "offering hope that an end to the pandemic is at han

on, 20.6M) reports lawmakers "burrowed into dueling positions over the impending impeachment trial" on Sunday, and the Washington Post (1/24, Wang, Dawsey, Goldstein, 10.52M) says "the fractures within the Republican Party were evident Sunday as GOP senators appeared split over whether it was constitut

plans with federal support." Fauci Reflects On "Difficulties, And The Toll," Of Working With Trump. In an interview with the New York Times (1/24, McNeil, 20.6M), NIAID Director Fauci "described some of the difficulties, and the toll, of working with President Donald 3. Trump." Asked about his plans

eral other members of the White House coronavirus task force raised concerns about Atlas or openly disputed his views." The Washington Post (11/30, Dawsey, Abutaleb, 14.2M) reports that while Atlas "fell out of favor with senior White House advisers in recent weeks, he was for several months the only

hose of another candidate that is about a week ahead from Pfizer and German firm BioNTech." In a 2,700-word article, the New York Times (11/30, Al, McNeil, 18.61M) says that while "good news about vaccines or antibody treatments surfaces" every week, "offering hope that an end to the pandemic is at ha

eral other members of the White House coronavirus task force raised concerns about Atlas or openly disputed his views." The Washington Post (11/30, Dawsey, Abutaleb, 14.2M) reports that while Atlas "fell out of favor with senior White House advisers in recent weeks, he was for several months the only

hose of another candidate that is about a week ahead from Pfizer and German firm BioNTech." In a 2,700-word article, the New York Times (11/30, Al, McNeil, 18.61M) says that while "good news about vaccines or antibody treatments surfaces" every week, "offering hope that an end to the pandemic is at ha